3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
25
Kidney Neoplasms
6
Neoplasms
5
Neoplasm Metastasis
4
Clear-cell metastatic renal cell carcinoma
4
Uterine Cervical Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Ovarian Neoplasms
2
Melanoma
2
Endometrial Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Pheochromocytoma
1
Paraganglioma
1
Neuroendocrine Tumors
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Lymphatic Metastasis
1
Lung Neoplasms
1
Kidney Diseases
1
Gastrointestinal Stromal Tumors
1
Fallopian Tube Neoplasms
1
Esophageal Neoplasms
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Interventions
fludarabine
52
Cyclophosphamide
50
venetoclax
47
Azacitidine
44
fludarabine phosphate
41
Whole-Body Irradiation
33
Specimen Handling
31
Mycophenolic Acid
30
Tacrolimus
28
Melphalan
28
Busulfan
27
Cytarabine
25
Stem Cell Transplantation
23
Decitabine
23
Biopsy
22
Granulocyte Colony-Stimulating Factor
19
Sirolimus
16
Peripheral Blood Stem Cell Transplantation
16
Filgrastim
16
Thiotepa
15
decitabine and cedazuridine drug combination
14
Injections
13
Cyclosporine
13
Methotrexate
9
Mesna
9
Hematopoietic Stem Cell Transplantation
9
ruxolitinib
8
X-Rays
8
Idarubicin
8
Daunorubicin
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
Axitinib
×
1 year
×
Clear all
No trials found.